GENZYME CORP Future Amortization Expense, Year Four (Deprecated 2012-01-31)
GENZYME CORP reported Future Amortization Expense, Year Four (Deprecated 2012-01-31) of $133.11 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearFour · last filed 2011-03-01
- GENZYME CORP future amortization expense, year four (deprecated 2012-01-31) for the quarter ending 2010-12-31 was $662.00K.
- GENZYME CORP future amortization expense, year four (deprecated 2012-01-31) for the quarter ending 2010-09-30 was -$2.97M.
- GENZYME CORP future amortization expense, year four (deprecated 2012-01-31) for fiscal 2010 was $133.11M.
| Period end | Future Amortization Expense, Year Four (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Year Four (Deprecated 2012-01-31) 6 month | Future Amortization Expense, Year Four (Deprecated 2012-01-31) 9 month | Future Amortization Expense, Year Four (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2010-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$2.31M derived: sum of 2 quarters · filed 2011-03-01 | $133.11M 10-K · filed 2011-03-01 | |
| 2010-09-30 | -$2.97M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $132.45M 10-Q · filed 2010-11-09 | ||
| 2010-06-30 | $135.42M 10-Q/A · filed 2010-09-07 |